Edwards Lifesciences up 4% at $87.50 after Q2 earnings beat and guidance
Edwards Lifesciences up 4% at $87.50 after Q2 earnings beat and guidance
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.